Virginia has joined a coalition of states to support a proposed federal rule aimed at increasing transparency from pharmacy ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Pharmacy Benefit Managers (PBMs) are accused of anticompetitive behavior that raises healthcare costs and harms patient care. The proposed FAIR Rx Act in Tennessee aims to stop PBMs from owning ...

When Congress created the 340B program in 1992, it was intended to lower the cost of medications for low-income and uninsured patients who relied on safety-net clinics and hospitals for their care.

Independent pharmacies say they're struggling to survive following the ongoing struggle with PBMs, and Senator Kaine says he is working to address the issues. Trump humiliates himself after calling ...

JACKSON, Miss. (MS Today) - As the Mississippi Legislature’s regular session enters what lawmakers hope are its final days, legislators on Monday appeared to settle the state’s biggest ticket item: ...

Cigna’s Express Scripts continued its lead in the U.S. pharmacy benefit manager market for the second year in a row, processing nearly one-third of all prescription claims, according to a March 30 ...

Sood is a senior scholar at the USC Schaeffer Center for Health Policy and Economics and a professor at the USC Sol Price School of Public Policy. Consumer groups, independent pharmacies, and ...

A legislative deadline caused several Mississippi bills to die, including ones on pharmacy, criminal justice, and land sales. A bill to regulate Pharmacy Benefit Managers (PBMs) died after the House ...

Kansas lawmakers are debating two bills aimed at reforming prescription drug pricing and regulating Pharmacy Benefit Managers (PBMs). Senate Bill 20, which passed both the House and Senate, seeks to ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. “Contrary to much of the independent-pharmacy lobby’s rhetoric, there is no crisis facing ...